JP2024528457A5 - - Google Patents
Info
- Publication number
- JP2024528457A5 JP2024528457A5 JP2023579049A JP2023579049A JP2024528457A5 JP 2024528457 A5 JP2024528457 A5 JP 2024528457A5 JP 2023579049 A JP2023579049 A JP 2023579049A JP 2023579049 A JP2023579049 A JP 2023579049A JP 2024528457 A5 JP2024528457 A5 JP 2024528457A5
- Authority
- JP
- Japan
- Prior art keywords
- insulin
- compound
- administered
- site
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2109087.3A GB202109087D0 (en) | 2021-06-24 | 2021-06-24 | Therapeutic methods and devices |
| GB2109087.3 | 2021-06-24 | ||
| PCT/EP2022/067148 WO2022268941A1 (en) | 2021-06-24 | 2022-06-23 | Therapeutic methods and devices |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024528457A JP2024528457A (ja) | 2024-07-30 |
| JP2024528457A5 true JP2024528457A5 (enExample) | 2025-06-30 |
Family
ID=77179556
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023579049A Pending JP2024528457A (ja) | 2021-06-24 | 2022-06-23 | 治療方法およびデバイス |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250276127A1 (enExample) |
| EP (1) | EP4358993A1 (enExample) |
| JP (1) | JP2024528457A (enExample) |
| CN (1) | CN117881417A (enExample) |
| GB (1) | GB202109087D0 (enExample) |
| MX (1) | MX2023015379A (enExample) |
| WO (1) | WO2022268941A1 (enExample) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5869602A (en) | 1995-03-17 | 1999-02-09 | Novo Nordisk A/S | Peptide derivatives |
| IL146496A0 (en) | 2001-11-14 | 2002-07-25 | Lycored Natural Prod Ind Ltd | Carotenoid composition and method for protecting skin |
| NZ541365A (en) | 2002-12-27 | 2009-09-25 | Diobex Inc | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
| MXPA06014970A (es) * | 2004-06-29 | 2007-03-07 | Diobex Inc | Composiciones y metodos para la prevencion y el control de la hipoglucemia inducida por la insulina. |
| CA2628241C (en) | 2005-11-07 | 2016-02-02 | Indiana University Research And Technology Corporation | Glucagon analogs exhibiting physiological solubility and stability |
| CN101578102B (zh) | 2007-01-05 | 2013-07-17 | 印第安纳大学研究及科技有限公司 | 在生理性pH缓冲液中显示增强的溶解性的胰高血糖素类似物 |
| MX2009008241A (es) | 2007-02-15 | 2009-10-08 | Univ Indiana Res & Tech Corp | Co-agonistas de receptor de glucagon/glp-1. |
| JP5385266B2 (ja) | 2007-06-15 | 2014-01-08 | ジーランド ファーマ アクティーゼルスカブ | グルカゴン類似体 |
| RO123581B1 (ro) * | 2009-01-29 | 2014-02-28 | D.M. Oana Toană | Metodă de monitorizare a glicemiei şi aparat de injectat insulină pacienţilor cu diabet zaharat |
| RU2014107515A (ru) | 2011-09-19 | 2015-10-27 | Фп Марангони Инк. | Трехфазная система сепарации для буровых растворов и бурового шлама |
-
2021
- 2021-06-24 GB GBGB2109087.3A patent/GB202109087D0/en not_active Ceased
-
2022
- 2022-06-23 EP EP22738582.0A patent/EP4358993A1/en active Pending
- 2022-06-23 MX MX2023015379A patent/MX2023015379A/es unknown
- 2022-06-23 US US18/572,594 patent/US20250276127A1/en active Pending
- 2022-06-23 JP JP2023579049A patent/JP2024528457A/ja active Pending
- 2022-06-23 CN CN202280057857.XA patent/CN117881417A/zh active Pending
- 2022-06-23 WO PCT/EP2022/067148 patent/WO2022268941A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI614024B (zh) | 超快起作用胰島素之用途 | |
| US20250360078A1 (en) | Extended release of neuregulin for treating heart failure | |
| JP5891216B2 (ja) | デスモプレシン薬物送達のための方法及びデバイス | |
| EP1386626A1 (en) | Delivery device for treatment of diabetes mellitus | |
| US20040059316A1 (en) | Medical delivery device | |
| Bode | Comparison of pharmacokinetic properties, physicochemical stability, and pump compatibility of 3 rapid-acting insulin analogues—aspart, lispro, and glulisine | |
| WO2013177565A1 (en) | Insulin-pramlintide compositions and methods for making and using them | |
| JP2003500119A (ja) | 小分子インスリン様物質の投薬装置及び投与法 | |
| JP2006514990A5 (enExample) | ||
| JP2006514990A (ja) | インスリン誘発性低血糖の予防および制御のための組成物および方法 | |
| Bode et al. | Efficacy and safety of insulin degludec 200 U/mL and insulin degludec 100 U/mL in patients with type 2 diabetes (Begin: Compare) | |
| US12514907B2 (en) | Treatment of exercise-induced hypoglycemia in type 1 and insulin using type 2 diabetes | |
| KR20200131812A (ko) | 대사 질병을 치료하기 위한 조성물 및 방법 | |
| Leppert et al. | Delivery systems of opioid analgesics for pain relief: a review | |
| JP7133229B2 (ja) | 糖尿病を治療するためのシステム、組成物および方法 | |
| KR20200003923A (ko) | 옥트레오티드 주사제 | |
| WO2016001185A1 (en) | Dosage regimen for the treatment of diabetes | |
| Umpierrez et al. | Concentrated insulins: clinical update of therapeutic options | |
| US20090186052A1 (en) | Use of botulinum toxin for porlonged local desensitization | |
| El-Laboudi et al. | Towards a physiological prandial insulin profile: enhancement of subcutaneously injected prandial insulin using local warming devices | |
| US20250276127A1 (en) | Therapeutic methods and devices | |
| WO2014071339A2 (en) | Uses of bremelanotide in therapy for female sexual dysfunction | |
| Raviele et al. | Patient-Activated Implantable Drug Pump for Treatment of Vasovagal Syncope: Is It Time for Clinical Use? | |
| CA3186427A1 (en) | Systems, devices, compositions and methods for treating diabetes | |
| EA044268B1 (ru) | Способ лечения неалкогольной жировой болезни печени |